Showing results (841-850 of 1,787) with videos related to

Sort By:
Pageof 179
Hepatology Communications|September 3, 2024
Long-term impact of scheduled regular endoscopic interventions for patients with primary sclerosing cholangitisBurcin Özdirik, Wilfried Veltzke-Schlieker, Jule Marie Nicklaus, et al.
Hepatology Communications|October 24, 2024
Cholestatic insult triggers alcohol-associated hepatitis in miceShengmin Yan, Zhen Lin, Michelle Ma, et al.
Hepatology Communications|October 4, 2024
Infections in decompensated cirrhosis: Pathophysiology, management, and research agendaJessica Ferguson Toll, Elsa Solà, Maria Alejandra Perez, et al.
Hepatology Communications|October 11, 2024
Transforming steatotic liver disease management: The emerging role of GLP-1 receptor agonistsEllen L Jensen, Mads Israelsen, Aleksander Krag
Hepatology Communications|October 11, 2024
Zinc supplementation to improve prognosis in patients with compensated advanced chronic liver disease: a multicenter, randomized, double-blind, placebo-controlled clinical trialJuan Bañares, Laia Aceituno, Lourdes Ruiz-Ortega, et al.
Hepatology Communications|October 4, 2024
Enhanced interactions within microenvironment accelerates dismal prognosis in HBV-related HCC after TACELibo Wang, Jiahui Cao, Zaoqu Liu, et al.
Hepatology Communications|July 31, 2024
Digital therapeutics lead to clinically significant body weight loss in patients with metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysisSomaya Albhaisi, Justin Tondt, John Cyrus, et al.
Hepatology Communications|August 5, 2024
Transcriptomic profiling of intermediate cell carcinoma of the liverByungchan Jang, So Mee Kwon, Jang Hyun Kim, et al.
Hepatology Communications|September 19, 2024
Steroid-refractory immune checkpoint inhibitor (ICI) hepatitis and ICI rechallenge: A systematic review and meta-analysisSoo Young Hwang, Pinghsin Hsieh, Wei Zhang
Hepatology Communications|August 5, 2024
Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapyPaul R Burchard, Luis I Ruffolo, Nicholas A Ullman, et al.
Pageof 179